Before the Bell
$
5.49
Change
+0.03 +0.55%
Volume
Volume 139
Nov 28, 2023, 4:33 a.m.
Quotes are delayed by 20 min
Previous close
$ 5.46
$ 5.46
Change
-0.11 -1.97%
Day low
Day high
$5.39
$5.61

52 week low
52 week high
$5.30
$18.55

Market cap
$661.66M
Average volume
7.43M
P/E ratio
N/A
Rev. per Employee
$526,989
EPS
-6.38
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on NVAX
-
Novavax Inc. stock falls Monday, underperforms market
- MarketWatch Automation
-
Novavax Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Novavax stock up 1.1% in premarket trades
- Steve Gelsi
-
Novavax Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Novavax Inc. stock underperforms Tuesday when compared to competitors
- MarketWatch Automation
-
Novavax Inc. stock falls Monday, underperforms market
- MarketWatch Automation
-
Novavax Inc. stock falls Friday, underperforms market
- MarketWatch Automation
-
Novavax Inc. stock falls Thursday, underperforms market
- MarketWatch Automation
-
Novavax Inc. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
Novavax Inc. stock underperforms Tuesday when compared to competitors
- MarketWatch Automation
-
Novavax Inc. stock rises Monday, outperforms market
- MarketWatch Automation
-
Novavax Inc. stock underperforms Friday when compared to competitors
- MarketWatch Automation
-
Novavax Inc. stock outperforms competitors despite losses on the day
- MarketWatch Automation
-
Novavax shares rise as third-quarter results top expectations
- Eleanor Laise
-
Novavax Inc. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
Novavax Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Novavax Inc. stock falls Monday, underperforms market
- MarketWatch Automation
-
Novavax Inc. stock falls Friday, underperforms market
- MarketWatch Automation
- Loading more headlines...
Analyst Ratings
Other News on NVAX
-
When to Get Your Covid-19, Flu and RSV Shots This Fall
- The Wall Street Journal Interactive Edition
-
Stocks Rise, While Bond Prices Decline
- The Wall Street Journal Interactive Edition
-
FDA Authorizes Novavax’s Updated Covid Vaccine
- The Wall Street Journal Interactive Edition
-
A Game Plan for Timing Your Flu, Covid and RSV Shots This Fall
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
Biden Waves Through Another Covid Booster
- The Wall Street Journal Interactive Edition
-
A New Omicron Subvariant, Dubbed ‘Eris,’ Heralds Covid-19’s Resurgence
- The Wall Street Journal Interactive Edition
-
A New Omicron Subvariant, Dubbed ‘Eris,’ Heralds Covid-19’s Resurgence
- The Wall Street Journal Interactive Edition
-
Next Covid Shots in the U.S. Will Target Omicron Offshoot XBB.1.5
- The Wall Street Journal Interactive Edition
-
U.S. to Target XBB Strain When Covid Shots Roll Out This Fall
- The Wall Street Journal Interactive Edition
-
Next Covid Boosters to Target New Strain
- The Wall Street Journal Interactive Edition
-
- Edgar Online - (EDG = 10Q, 10K)
-
New Covid-19 Booster Shots: What to Know
- The Wall Street Journal Interactive Edition
-
Single Dose of Omicron-Targeting Vaccines to Become Main Covid-19 Shot in U.S.
- The Wall Street Journal Interactive Edition
-
The Government’s Covid Casualties
- The Wall Street Journal Interactive Edition
-
S&P 500 Ticks Lower After Manufacturing Data
- The Wall Street Journal Interactive Edition
-
- Edgar Online - (EDG = 10Q, 10K)
-
Graham Capital Management, L.P. Buys 1, Sells 4 in 4th Quarter
- GuruFocus.com
-
Novavax to Sell 1.5 Million More Covid Vaccines to U.S.
- The Wall Street Journal Interactive Edition
-
FDA Advisers Back Annual Covid-19 Boosters With Reservations About Rollout
- The Wall Street Journal Interactive Edition
- Loading more headlines...
Press Releases on NVAX
-
Novavax Reports First Quarter 2023 Financial Results and Operational Highlights
- PR Newswire - PRF
-
Novavax to Participate in the BofA Securities 2023 Health Care Conference
- PR Newswire - PRF
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com